GUIDELINES FOR ADVERTISEMENTS FOR RECRUITING SUBJECTS

You can also download this page in PDF | MS Word format.

Federal Regulations require that the IRB review and approve methods used to recruit subjects, one of which is the use of advertisements in various media. The text of all direct advertising for research subjects, i.e., advertising that is intended to be seen or heard by prospective subjects, must be reviewed and approved by the NYU SOM IRB prior to distribution, posting, publication, or broadcasting. Direct advertising includes, but is not limited to, notices aimed at recruiting research subjects that investigators intend to place in newspaper, radio, TV, bulletin boards and the internet/world wide web. Notices directed to clinical colleagues seeking study referrals also require NYU SOM IRB approval. These include, but are not limited to, letters, electronic and other postings, or notices in professional publications. NYU SoM IRB uses the following guidelines when assessing advertisements.
Advertisements should include:

• Name of research facility;
• Purpose of the research and eligibility criteria (briefly stated);
• Time commitment and remuneration;
• Contact person for more information;
• The word "research" somewhere prominent in the advertisement.

Advertisements should not include:

• Claims, explicit or implicit, that the drug, biologic or device is safe or effective for the purposes under investigation or that the test article (drug, biologic, device) is known to be equivalent or superior to any other drug, biologic or device; and
• References to "new treatment", "new medication" or "new drug" without explaining that the drug, biologic or device is investigational.

All advertisements should be tastefully composed and not inappropriately emphasize monetary remuneration. If you wish to use NYU SOM logos, contact Public Affairs for relevant guidelines.
Do:

• USE THE WORD "RESEARCH" in your advertisement, the terms "Study" or "Treatment Study" do not convey the same message
• Provide information prospective subjects need to determine interest, such as eligibility, significant study procedures, and time commitment
• males, females, adults, children, age range, taking no medications, etc.
• x-rays, MRIs, exercise testing, overnight stays, frequent blood sampling, etc.
• duration of study, number of visits and/or length of visits, if only one or two visits
• Use "healthy volunteers" instead of "normal volunteers"
• Use simple lay language without acronyms or abbreviations unless these are well known to the public or to the special patient group you are targeting, e.g., patients with ALS or women with PMS will understand these abbreviations
• Provide simple symptom complexes if you are looking for subjects who do not already carry the diagnosis
• Provide basic exclusion criteria whenever possible to reduce unnecessary calls
• Use the word "investigational " rather than "experimental"
• Name drugs used if approved and/or known to the public, e.g., Aspirin, St. John's Wort
• Use the words "at no cost" rather than "free" where relevant
• Specify hospital affiliation (e.g. Cardiovascular Division, BHC)
• Indicate where the ad is going to be placed/posted, if the same text will be used for email, newspaper, radio, web, etc.
• Submit printed ads as they will appear in print (or as close as possible) so the reviewer can assess the visual impact, emphasis and graphic message
• Submit the full text of radio or television ads

Don't:

• Feature monetary compensation as a lead in before the description of study purpose and procedures
• Bold, italicize, underline or enlarge fonts on type describing monetary compensation
• Imply treatment benefit if the primary focus of the study is safety and tolerability, drug kinetics, or basic physiological processes rather than efficacy
• Imply treatment benefit for chronic problems if the study involves only short-term interventions
• Emphasize no cost treatment if a placebo is involved (you don't need to explicitly state that placebos are used in ads) and/or the protocol involves drugs, biologics, or devices not FDA approved for the condition under study
• Provide detailed lists of risks and benefits (this should be done in person)
• "Hype" the study with overly optimistic or effusive language implying benefit (commercially designed radio ads occasionally do this)
• Specify exact monetary compensation amounts

Notices or letters sent to other health care providers